[Tree] Analyst ratings, insider trading, and stock acquisition at Doximity, CG Oncology, and DocuSign
Version 0.13 (2024-06-09 04:54:15.720000)
updates: Morgens Waterfall Vintiadis & Co. Inc. acquires new position in DocuSign
- ➔
- ➔
- ➔
Version 0.11 (2024-03-02 20:23:05.764000)
updates: Analyst ratings and insider trading activity at Doximity, Inc.; CG Oncology shares decline
- ➔
- ➔
Version 0.09 (2024-02-29 13:54:21.593000)
updates: The addition of information about Envestnet Portfolio Solutions Inc.'s investment in Globus Medical, Inc. (NYSE:GMED)
- ➔
Version 0.08 (2024-02-28 21:06:08.426000)
updates: Includes information about DexCom Inc (DXCM) stock in the medical devices industry
- ➔
Version 0.07 (2024-02-24 10:57:55.542000)
updates: Swiss National Bank and Korea Investment Corp adjust holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX) and Cognex Co. (NASDAQ:CGNX)
- ➔
Version 0.06 (2024-02-24 10:13:44.446000)
updates: Swiss National Bank increases holdings in Celldex Therapeutics
- ➔
Version 0.05 (2024-01-19 20:50:22.504000)
updates: Added information about Cullinan Oncology Inc (CGEM) stock
- ➔
Version 0.04 (2024-01-12 18:03:47.365000)
updates: Added information about the performance and ratings of GDRX stock
- ➔
Version 0.03 (2023-12-12 20:17:48.910000)
updates: Added information about the performance and ratings of CKPT stock
- ➔
- ➔
- ➔
Version 0.02 (2023-12-12 20:17:25.874000)
updates: Added information about the performance and ratings of CGTX stock
- ➔
- ➔
Version 0.01 (2023-11-28 17:49:01.284000)
updates: Stock performance and rating of MacroGenics Inc (MGNX)
- ➔